Pre-infusion ferritin a predictive biomarker for CAR T-cell therapy in R/R multiple myeloma

Pre-infusion ferritin a predictive biomarker for CAR T-cell therapy in R/R multiple myeloma

IntroductionEvaluating predictive biomarkers early in treatment, clinicians can anticipate Q7 77 78 survival outcomes. Ferritin has emerged as a promising predictor of clinical 79 outcomes in multiple myeloma (MM) patients undergoing chimeric antigen patient responses and tailor therapeutic strategi...

Full description

Saved in:
Bibliographic Details
Main Authors: Eider F. Moreno-Cortes, Mariano Arribas, David A. Martinez-Gamboa, Juana Figueroa-Aguirre, Rohan Patel, Daniel Bihnam, Udit Yadav, J. Erin Wiedmeier-Nutor, Leif Bergsagel, Saurabh Chhabra, Rafael Fonseca, Januario E. Castro
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Hematology
Subjects:
CAR T cell
multiple myeloma
ferritin
C reactive protein (CRP)
ciltacabtagene autoleucel
idecabtagene vicleucel
Online Access:https://www.frontiersin.org/articles/10.3389/frhem.2025.1618331/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items